Correlation Between Instil Bio and Inhibikase Therapeutics
Can any of the company-specific risk be diversified away by investing in both Instil Bio and Inhibikase Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Instil Bio and Inhibikase Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Instil Bio and Inhibikase Therapeutics, you can compare the effects of market volatilities on Instil Bio and Inhibikase Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Instil Bio with a short position of Inhibikase Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Instil Bio and Inhibikase Therapeutics.
Diversification Opportunities for Instil Bio and Inhibikase Therapeutics
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Instil and Inhibikase is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Instil Bio and Inhibikase Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibikase Therapeutics and Instil Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Instil Bio are associated (or correlated) with Inhibikase Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibikase Therapeutics has no effect on the direction of Instil Bio i.e., Instil Bio and Inhibikase Therapeutics go up and down completely randomly.
Pair Corralation between Instil Bio and Inhibikase Therapeutics
Considering the 90-day investment horizon Instil Bio is expected to under-perform the Inhibikase Therapeutics. In addition to that, Instil Bio is 1.08 times more volatile than Inhibikase Therapeutics. It trades about -0.16 of its total potential returns per unit of risk. Inhibikase Therapeutics is currently generating about -0.08 per unit of volatility. If you would invest 274.00 in Inhibikase Therapeutics on August 28, 2024 and sell it today you would lose (40.00) from holding Inhibikase Therapeutics or give up 14.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Instil Bio vs. Inhibikase Therapeutics
Performance |
| Timeline |
| Instil Bio |
| Inhibikase Therapeutics |
Instil Bio and Inhibikase Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Instil Bio and Inhibikase Therapeutics
The main advantage of trading using opposite Instil Bio and Inhibikase Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Instil Bio position performs unexpectedly, Inhibikase Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibikase Therapeutics will offset losses from the drop in Inhibikase Therapeutics' long position.| Instil Bio vs. Eliem Therapeutics | Instil Bio vs. Scpharmaceuticals | Instil Bio vs. Milestone Pharmaceuticals | Instil Bio vs. Seres Therapeutics |
| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |